Heart Failure Symptoms Identified With Home Monitoring Predict Subsequent Shock and DeathDyssynchronyventricular pacingcalcium handling proteinmitogen-activated protein kinaseheart failureBackground: Right ventricular (RV) apical pacing may result in ventricular dyssynchrony, which is associated with functional ...
Living With Depressive Symptoms: Patients With Heart Failure Patients with heart failure often experience depressive symptoms that affect health-related quality of life, morbidity, and mortality. Researchers have not... RL Dekker,AR Peden,TA Lennie,... - 《American Journal of Critical Care》 被引...
Methods: We studied 1462 consecutive heart failure (HF) patients admitted to our hospital from 2006-2010 with HF symptoms. Left ventricular ejection fraction (LVEF) was evaluated by echocardiography during hospitalization. Specific cause of death within 1 year's follow-up was compared between HFPEF ...
The research led by the University of Otago's Christchurch Heart Institute (CHI) studied C-type natriuretic peptides (CNP) in 2,129 people admitted to hospital with heart attack symptoms. The team is internationally recognised for its research into A and B-type natriuretic peptides (ANP and ...
Heart failure management using implantable devices for ventricular resynchronization: Comparison of medical therapy, pacing, and defibrillation in chronic ... Background: Although pharmacological therapy has ameliorated symptoms and improved the survival of patients with chronic heart failure (CHF), this chr...
AimsOur aim is to determine mortality and morbidity in Asian patients under clinical management for heart failure (HF). Specifically, we will define the incidence of, and risk factors for, sudden cardiac death, as well as the socio-cultural factors influencing therapeutic choices in these patients...
As the heart is an energy-demanding organ, impaired cardiac energy metabolism and mitochondrial function have been inexorably linked to cardiac dysfunction
Previous studies demonstrated that sudden death may be preceded by premonitory symptoms in the days, weeks, or months before the event.6, 7, 8 Less is known about the frequency of medical encounters and symptoms at last medical visits prior to sudden death. Such information may identify high-...
Dapagliflozin reduced the risk of worsening heart failure events and cardiovascular death and improved symptoms.12,13 The key question arising from the DAPA-HF trial is how the effects of dapagliflozin compared in patients with and without diabetes, and whether the findings of this trial support ...
A method for screening, diagnosis or prognosis of sudden death in heart failure in a mammalian subject, for determining sudden death in heart failure in a mammalian subject, for ide